{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:17Z","timestamp":1792782617010,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kyowa Kirin International","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"https:\/\/ror.org\/017hh7b56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-induced osteomalacia (TIO) is an ultra-rare, paraneoplastic syndrome caused by tumors secreting fibroblast growth factor 23 (FGF23). In children, TIO may be mistaken for more common causes of rickets and osteomalacia, including monogenic forms, leading to long diagnostic delays. This review aimed to identify evidence on the diagnostic journey and burden of TIO in pediatric patients. A literature review was conducted to identify publications reporting disease characteristics, investigations, treatments, and clinical outcomes in pediatric patients diagnosed with TIO. In total, 41 studies were included in the review, reporting on 46 pediatric patients. Mean age at presentation was 11.2 years (standard deviation [SD]: 4.6). The majority of individuals (60.9%) were male. The most commonly reported symptoms at presentation were pain (65.2%), weakness (47.8%), and impaired physical function (43.5%). Rickets was reported in 45.7% of patients and fractures in 34.8% of patients. Mean time from onset of symptoms to diagnosis was 4.3 years (SD: 2.6) and mean number of imaging procedures per patient was 5.4 (SD: 2.7). Low serum phosphate concentration for age was reported in 93.5% of patients at presentation. Attempted surgical resection was reported in the majority of patients (89.1%) and was successful in 60.9%. Pediatric-onset TIO is associated with a substantial symptomatic and healthcare burden. Increasing awareness of TIO in children may prevent delays in diagnosis, reduce the need for radiation-conferring tests, and lower morbidity due to effective management. Further research in this area is needed to address the scarcity of data available in pediatric patients.<\/jats:p>","DOI":"10.1007\/s00223-026-01580-0","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:05:41Z","timestamp":1786345541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of Disease in Pediatric Tumor-Induced Osteomalacia: A Literature Review"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9386-7732","authenticated-orcid":false,"given":"Suzanne M.","family":"Jan de Beur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6768","authenticated-orcid":false,"given":"Thomas O.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-9138","authenticated-orcid":false,"given":"Kathryn M.","family":"Dahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9397-1847","authenticated-orcid":false,"given":"Mar\u00eda Bel\u00e9n","family":"Zanchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-0920","authenticated-orcid":false,"given":"Ben","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-0837","authenticated-orcid":false,"given":"Neil","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Broadhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-3467","authenticated-orcid":false,"given":"Erik A.","family":"Imel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"1","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108(1):128\u2013142","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18(3):R53\u201377","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/joim.13593","volume":"293","author":"SM Jan de Beur","year":"2023","unstructured":"Jan de Beur SM, Minisola S, Xia WB, Abrahamsen B, Body JJ, Brandi ML et al (2023) Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. J Intern Med 293(3):309\u2013328","journal-title":"J Intern Med"},{"issue":"2","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"e10436","DOI":"10.1002\/jbm4.10436","volume":"5","author":"F Jerkovich","year":"2021","unstructured":"Jerkovich F, Nu\u00f1ez S, Mocarbel Y, Pignatta A, El\u00edas N, Cassinelli H et al (2021) Burden of disease in patients with tumor-induced osteomalacia. JBMR Plus 5(2):e10436","journal-title":"JBMR Plus"},{"issue":"9","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00198-022-06432-9","volume":"33","author":"S Minisola","year":"2022","unstructured":"Minisola S, Barlassina A, Vincent SA, Wood S, Williams A (2022) A literature review to understand the burden of disease in people living with tumour-induced osteomalacia. Osteoporos Int 33(9):1845\u20131857","journal-title":"Osteoporos Int"},{"issue":"8","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00198-025-07469-2","volume":"36","author":"J Lasnier-Siron","year":"2025","unstructured":"Lasnier-Siron J, Perret R, Jaafar A, Schaeverbeke T, Cetre NM (2025) Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia. Osteoporos Int 36(8):1481\u20131485","journal-title":"Osteoporos Int"},{"issue":"1","key":"1580_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/BPB.0b013e32832f59cb","volume":"19","author":"GH Jung","year":"2010","unstructured":"Jung GH, Kim JD, Cho Y, Chung SH, Lee JH, Sohn KR (2010) A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets. J Pediatr Orthop B 19(1):127\u2013132","journal-title":"J Pediatr Orthop B"},{"key":"1580_CR8","doi-asserted-by":"publisher","first-page":"100744","DOI":"10.1016\/j.bonr.2020.100744","volume":"14","author":"JM Colazo","year":"2021","unstructured":"Colazo JM, DeCorte JA, Gillaspie EA, Folpe AL, Dahir KM (2021) Hiding in plain sight: gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia. Bone Rep 14:100744","journal-title":"Bone Rep"},{"issue":"2","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00223-021-00843-2","volume":"109","author":"B Abrahamsen","year":"2021","unstructured":"Abrahamsen B, Smith CD, Minisola S (2021) Epidemiology of tumor-induced osteomalacia in Denmark. Calcif Tissue Int 109(2):147\u2013156","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00223-023-01148-2","volume":"113","author":"M May","year":"2023","unstructured":"May M, Oheim R, Bovy L, Doess A, Maessen D, Neukirch B et al (2023) Epidemiology of tumor-induced osteomalacia in Germany based on real world data. Calcif Tissue Int 113(6):630\u2013639","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1580_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/clinem\/dgae431","volume":"110","author":"SM Jan de Beur","year":"2024","unstructured":"Jan de Beur SM, Dahir KM, Imel EA, Zanchetta MB, Williams A, Li Z et al (2024) Healthcare resource use associated with tumor-induced osteomalacia: a literature review. J Clin Endocrinol Metab 110(1):102\u2013113","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jbmr.4233","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R et al (2021) Burosumab for the treatment of tumor-induced osteomalacia. J Bone Min Res 36(4):627\u2013635","journal-title":"J Bone Min Res"},{"issue":"6","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M et al (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Min Res 28(6):1386\u20131398","journal-title":"J Bone Min Res"},{"issue":"6","key":"1580_CR14","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D et al (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91(6):2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","volume":"4","author":"Z Yin","year":"2018","unstructured":"Yin Z, Du J, Yu F, Xia W (2018) Tumor-induced osteomalacia. Osteoporos Sarcopenia 4(4):119\u2013127","journal-title":"Osteoporos Sarcopenia"},{"key":"1580_CR16","unstructured":"Food and Drug Administration (FDA) (2020) CRYSVITA in tumor-induced osteomalacia. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761068s005lbl.pdf. Accessed Oct 2025"},{"key":"1580_CR17","unstructured":"European Medicines Agency (EMA) (2022) Crysvita (burosumab) for tumor-induced osteomalacia. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/crysvita. Accessed Oct 2025"},{"key":"1580_CR18","unstructured":"Minisola S, Jan de Beur S, Carpenter T, Dahir K, Zanchetta MB, Ward LM et al Supplementary material to \u2018burden of disease in pediatric tumor-induced osteomalacia: a literature review.\u2019 Dryad Digital Repository no longer in use, please see manuscript Supplement"},{"issue":"2","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","volume":"26","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M et al (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26(2):103\u2013109","journal-title":"Bone"},{"issue":"1","key":"1580_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12891-020-03796-z","volume":"21","author":"Z Engstrom","year":"2020","unstructured":"Engstrom Z, Wolf O, Hailer YD (2020) Epidemiology of pediatric femur fractures in children: the Swedish fracture register. BMC Musculoskelet Disord 21(1):796","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/17453671003628780","volume":"81","author":"EM Hedstrom","year":"2010","unstructured":"Hedstrom EM, Svensson O, Bergstrom U, Michno P (2010) Epidemiology of fractures in children and adolescents. Acta Orthop 81(1):148\u2013153","journal-title":"Acta Orthop"},{"issue":"9","key":"1580_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/biom15091321","volume":"15","author":"A Antonowicz","year":"2025","unstructured":"Antonowicz A, Lipinski P, Popow M, Skrzypczyk P (2025) Approach to a child with hypophosphatemia. Biomolecules 15(9):1321","journal-title":"Biomolecules"},{"issue":"8","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"e10661","DOI":"10.1002\/jbm4.10661","volume":"6","author":"IR Hartley","year":"2022","unstructured":"Hartley IR, Roszko KL, Li X, Pozo K, Streit J, Del Rivero J et al (2022) Infigratinib reduces fibroblast growth factor 23 (FGF23) and increases blood phosphate in tumor-induced osteomalacia. JBMR Plus 6(8):e10661","journal-title":"JBMR Plus"},{"issue":"6","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3174\/ajnr.A7513","volume":"43","author":"JC Benson","year":"2022","unstructured":"Benson JC, Trejo-Lopez JA, Nassiri AM, Eschbacher K, Link MJ, Driscoll CL et al (2022) Phosphaturic mesenchymal tumor. AJNR Am J Neuroradiol 43(6):817\u2013822","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"1580_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","volume":"111","author":"A Bosman","year":"2022","unstructured":"Bosman A, Palermo A, Vanderhulst J, De Beur SMJ, Fukumoto S, Minisola S et al (2022) Tumor-induced osteomalacia: a systematic clinical review of 895 cases. Calcif Tissue Int 111(4):367\u2013379","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","volume":"107","author":"D Rendina","year":"2022","unstructured":"Rendina D, Abate V, Cacace G, D\u2019Elia L, De Filippo G, Del Vecchio S et al (2022) Tumor-induced osteomalacia: a systematic review and individual patient\u2019s data analysis. J Clin Endocrinol Metab 107(8):e3428\u2013e36","journal-title":"J Clin Endocrinol Metab"},{"key":"1580_CR27","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.bonr.2024.101772","volume":"21","author":"N \u00c1lvarez-Rivas","year":"2024","unstructured":"\u00c1lvarez-Rivas N, Lugo-Rodr\u00edguez G, Maneiro JR, I\u00f1iguez-Ubiaga C, Melero-Gonzalez RB, Iglesias-Cabo T et al (2024) Tumor-induced osteomalacia: a systematic literature review. Bone Rep 21:101772","journal-title":"Bone Rep"},{"issue":"5","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/clinem\/dgac650","volume":"108","author":"X Ni","year":"2023","unstructured":"Ni X, Liu W, Zhang D, Li X, Chi Y, Feng J et al (2023) Hyperparathyroidism in a large cohort of chinese patients with tumor-induced osteomalacia. J Clin Endocrinol Metab 108(5):1224\u20131235","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMc2405746","volume":"392","author":"Y Hoshino","year":"2025","unstructured":"Hoshino Y, Okamoto K, Ogawa T, Kato H, Irie K, Watanabe S et al (2025) Acquired osteomalacia associated with autoantibodies against PHEX. N Engl J Med 392(5):513\u2013515","journal-title":"N Engl J Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01580-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:33:40Z","timestamp":1791848020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01580-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01580-0","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Reference 18 has been corrected","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"126"}}